What Is NMN? Benefits, Dosage, and What the Human Trials Actually Show
NMN is everywhere in the longevity space. I dug into what the human trials actually show, where the hype outpaces the evidence, and why the methylation problem matters more than most people realize.
This page contains affiliate links. I earn a commission if you purchase through my links, at no extra cost to you. I personally use and pay for the products reviewed here.
NMN stands for nicotinamide mononucleotide. It's a molecule your body already makes in small amounts. When you swallow it as a supplement, it converts into NAD+ (nicotinamide adenine dinucleotide), a coenzyme that every cell in your body uses for energy production, DNA repair, and a long list of other metabolic processes.
NAD+ levels drop as you age. By 50 you have roughly half the NAD+ you had at 20. The pitch behind NMN supplementation is straightforward: put the raw material back in, boost NAD+ levels, and your cells work better.
That's the theory. Does the evidence back it up?
See also: NAD+ levels by age: the decline nobody warned you about
NMN benefits: what the human clinical trials show
A 2022 study published in Science found that 250 mg of NMN daily improved muscle insulin sensitivity and muscle remodeling in older women. A separate trial showed that oral NMN safely and measurably increases blood NAD+ levels in healthy adults. DoNotAge's own clinical trial using their sachet formulation demonstrated a 76% increase in NAD+ levels.
These are real results in real humans. Not mice, not cell cultures. The NAD+ increase is consistent and reproducible across multiple trials.
I want to be honest about what we don't know yet, though. Most human NMN trials are small (under 100 participants) and short (under 12 weeks). We have good evidence that NMN raises NAD+. We have early evidence that higher NAD+ improves certain metabolic markers. We don't have large, long-term studies proving that NMN supplementation extends human lifespan. The mouse data on lifespan extension is strong. The human lifespan data isn't there yet.
NMN and the methylation problem
NMN doesn't just boost NAD+ and call it a day. The conversion process consumes methyl groups from your body's methylation pool. Methylation is how your body regulates gene expression, builds neurotransmitters, processes hormones, and handles detoxification.
If you take NMN without replenishing those methyl groups, you create a biochemical bottleneck. Your NAD+ goes up, but your methylation capacity goes down. It's like running your car engine harder while draining the oil.
TMG (trimethylglycine) solves this. It's a methyl donor that feeds directly into the methylation cycle. Taking TMG alongside NMN keeps the system balanced. Ca-AKG helps from the other direction, supporting the demethylation side so your epigenetic machinery doesn't get stuck.
Most people taking standalone NMN capsules don't pair it with TMG. That's a mistake. The two should always go together. The DoNotAge sachet includes both, which is one of the smarter formulation decisions in the product.
NMN bioavailability: how much actually gets absorbed?
Some people in the biohacking community claim oral NMN has near-zero bioavailability. That's overstated.
Oral NMN does undergo metabolism in the gut. Gut bacteria break down a portion of it into nicotinamide (NAM) before it reaches systemic circulation. A 2024 study using isotope-labeled NMN confirmed that oral delivery leads to extensive first-pass metabolism with limited incorporation of intact NMN into tissues.
Liposomal delivery protects NMN from gut degradation. Some sources claim up to 8x greater absorption. Sublingual delivery (under the tongue) bypasses the gut entirely.
But "reduced absorption" is not the same as "zero absorption." Multiple human trials using standard oral NMN have shown measurable, significant NAD+ increases. DoNotAge's 76% increase was achieved with their non-liposomal sachet. The molecule is getting through. The debate is about efficiency, not whether it works at all.
See also: NMN bioavailability: liposomal vs. capsule vs. powder
NMN dosage: how much to take
Human trial doses range from 250 mg to 1,000 mg daily. Most longevity researchers who publicly share their protocols take 500 mg to 1 g. DoNotAge's standalone capsules deliver 500 mg each, with a recommended serving of two capsules (1 g/day).
For someone starting out, 250 to 500 mg is a reasonable entry point. Pair it with at least 500 mg of TMG. If you feel good after a month and your budget allows, consider increasing to 1 g of NMN with 1 g of TMG.
The only way to know whether NMN is moving the needle for you personally is to test your NAD+ levels before starting and again after 30 to 60 days. DoNotAge sells an at-home NAD+ test kit. Jinfiniti offers a more detailed intracellular NAD+ test. Either works.
See also: How to test your NAD+ levels at home
Frequently asked questions
What does NMN do in the body?
NMN converts to NAD+, a coenzyme involved in energy production, DNA repair, and over 500 enzymatic reactions. Boosting NAD+ through NMN supplementation may improve metabolic function and support cellular repair processes that decline with age.
Is NMN safe to take daily?
Human trials at doses of 250 mg to 1,000 mg daily have shown no significant adverse effects. Long-term safety data beyond 12 weeks is limited. Always pair NMN with TMG to avoid methylation depletion.
How long does NMN take to work?
NAD+ levels typically increase within 2 to 4 weeks of consistent daily use. Subjective effects like improved energy may take longer. Lab testing at 30 and 60 days provides objective confirmation.
Should I take liposomal NMN or regular NMN?
If your dose is 500 mg or higher, regular oral NMN works fine based on clinical trial data showing significant NAD+ increases. If you're taking a lower dose and want maximum absorption per milligram, liposomal may be worth the premium.
What's the difference between NMN and NR?
Both are NAD+ precursors. NMN converts to NAD+ in one enzymatic step. NR (nicotinamide riboside) takes two steps. Some studies show comparable NAD+ increases at similar doses. NMN has more recent clinical trial data.